Document Detail


Baroreflex mechanisms buffering alpha-adrenergic agonists in conscious dogs.
MedLine Citation:
PMID:  2889369     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To determine the relative importance of the mechanisms utilized by the arterial baroreflex in buffering the pressor and vasoconstrictor responses to alpha-adrenergic receptor agonists, we studied responses to norepinephrine and phenylephrine in conscious dogs. The dogs were studied 2-8 wk after instrumentation with aortic catheters and aortic electromagnetic flow probes to measure arterial pressure and cardiac output. Total peripheral resistance was calculated on-line by a digital computer. The dogs were studied after beta-adrenergic receptor blockade (propranolol 1.0 mg/kg) to eliminate the complicating inotropic effects of the agonists studied. Norepinephrine (0.2 microgram/kg bolus) increased mean arterial pressure by 30 +/- 3 mmHg, total peripheral resistance by 51 +/- 4 mmHg . l-1 . min-1, and decreased heart rate by 26 +/- 3 beats/min. After arterial baroreceptor denervation, norepinephrine increased mean arterial pressure by 69 +/- 8 mmHg, total peripheral resistance by 48 +/- 6 mmHg . l-1 . min-1, and heart rate did not change. After ganglionic blockade (hexamethonium 40 mg/kg), norepinephrine increased mean arterial pressure by 76 +/- 3 mmHg, total peripheral resistance by 47 +/- 4 mmHg X l-1 X min-1, and heart rate did not change. Only after elimination of the buffering by heart rate by use of cholinergic receptor blockade (atropine 0.1 mg/kg) or ventricular pacing could buffering of the vasoconstrictor responses to alpha-adrenergic receptor agonists be demonstrated. Thus in conscious dogs the primary mechanism for buffering increases in arterial pressure induced by alpha-adrenergic receptor agonists is compensatory changes in heart rate and cardiac output with little buffering of total peripheral resistance.
Authors:
A M Fujii; S F Vatner
Related Documents :
18406419 - Study of the interaction of beta-cyclodextrin with phospholipid monolayers by surface p...
886469 - Leakage of dl-propranolol from cerebrospinal fluid to the bloodstream in the rabbit.
6130109 - Abnormal beta-adrenergic responsiveness in allergic subjects. ii. the role of selective...
2908819 - Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy o...
7421629 - Long-term experiences with labetalol.
1330939 - Cardiac beta-adrenergic mediated chrono- and inotropic effects of imipramine in vitro.
1858949 - Cholecystokinin in nucleus tractus solitarii modulates tonic and phasic gastric pressure.
15462539 - Evaluation of initial posttrauma cardiovascular levels in association with acute ptsd s...
12227629 - Circulatory effects of internal jugular vein compression: a computer simulation study.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of physiology     Volume:  253     ISSN:  0002-9513     ISO Abbreviation:  Am. J. Physiol.     Publication Date:  1987 Oct 
Date Detail:
Created Date:  1987-11-19     Completed Date:  1987-11-19     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370511     Medline TA:  Am J Physiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  H728-36     Citation Subset:  IM; S    
Affiliation:
Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Agonists / pharmacology*
Animals
Automatic Data Processing
Blood Pressure
Cardiac Output
Denervation
Dogs
Heart Rate / drug effects
Hexamethonium
Hexamethonium Compounds / pharmacology
Norepinephrine / pharmacology
Phenylephrine / pharmacology
Pressoreceptors / physiology*
Propranolol / pharmacology
Reference Values
Reflex / physiology*
Vascular Resistance
Vasoconstriction / drug effects
Grant Support
ID/Acronym/Agency:
HL-33107/HL/NHLBI NIH HHS; HL-33743/HL/NHLBI NIH HHS; RR-00168/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 0/Hexamethonium Compounds; 51-41-2/Norepinephrine; 525-66-6/Propranolol; 59-42-7/Phenylephrine; 60-26-4/Hexamethonium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Facilitatory role of efferent renal nerve activity on renal sensory receptors.
Next Document:  Vasoconstrictor role for vasopressin in conscious, sodium-depleted rats.